Mar 1, 2026 Log in

News

[PEL-BIOTECH-Inc] March 2026 Monthly Revenue NT$2M (YoY +74.5%)

Citation-Grade Primary-source linked Schema.org verified NQ 46 / 100

Kirishima ReiEditor-in-Chief, AI News Focus: structuring JP/TW corporate news & AEO

Published Mar 1, 2026 9:00 AM ・ Updated Jun 1, 2026 1:10 PM ・ 2 min read ・ Source: PR Times

Show contents

⚡ Key Points

PEL-BIOTECH-Inc announced its monthly revenue for March 2026.
Although the amount was small at NT$2 million, it recorded a significant 74.5% increase year-over-year, showing signs of rapid growth.

PEL-BIOTECH-Inc announced its monthly revenue for March 2026. Although the amount was small at NT$2 million, it recorded a significant 74.5% increase year-over-year, showing signs of rapid growth.

PRIMARY SOURCE Original source: https://openapi.twse.com.tw/revenue/twse-rev-6949-11503 Distributor: PR Times
Published: Mar 1, 2026

Company Code: 6949 Company Name: PEL-BIOTECH-Inc Industry: Biotechnology and Medical Care Data Month: 2026-03 Monthly Revenue: 2,454 thousand TWD (0.002 billion) Year-over-year Change: +74.5%

FACT BOX

Source: PR Times
Category: News
Dates in source: 2026-03

Editorial & Verification Standards

The Washin AI News desk structures and reviews this article under the following standards.

Start only from primary sources (official PR, disclosures, wire services)
Numbers and proper nouns machine-checked against the source (number-completeness check)
Company names and tickers verified via registry (Registry/TWSE/Wikidata)
No speculation; nothing stated that is not in the source

Read the full editorial policy →

Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›

Announced　Mar 1, 2026 9:00 AM — Distributor PR Times
Collected　Apr 12, 2026 4:30 PM
AI structured & analyzed　Apr 13, 2026 11:43 AM
Desk-reviewed & published　Mar 1, 2026 9:00 AM

FAQ

What are the key facts in this article?

PEL-BIOTECH-Inc announced its monthly revenue for March 2026. Although the amount was small at NT$2 million, it recorded a significant 74.5% increase year-over-year, showing signs of rapid growth.

Where is the primary source?

PR Times: https://openapi.twse.com.tw/revenue/twse-rev-6949-11503

When was it published?

Mar 1, 2026

Cite this article — HOW TO CITE

Washin AI News Desk“[PEL-BIOTECH-Inc] March 2026 Monthly Revenue NT$2M (YoY +74.5%)”AI News by Washin Village（和心村）, Mar 1, 2026. https://aeo.idaeo.ai/ai/%E6%B2%9B%E7%88%BE%E7%94%9F%E9%86%AB-%E5%89%B5/en/news/2026-03-01-pel-biotech-inc-march-2026-monthly-reven

AI CRAWLER ACTIVITY

as of Aug 21, 2026

AI crawler visits to this article (cumulative)Measuring since publication (no visits recorded yet)

Site-wide cumulative

Applebot

bot_visits_summary

2314k

last Aug 21, 2026

GPTBot

bot_visits_summary

1895k

last Aug 21, 2026

ClaudeBot

bot_visits_summary

1429k

last Aug 21, 2026

Amazonbot

bot_visits_summary

697k

last Aug 21, 2026

Bingbot

bot_visits_summary

531k

last Aug 21, 2026

Meta AI

bot_visits_summary

325k

last Aug 21, 2026

※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.

Washin AI News（AI News by Washin Village（和心村））

An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.

Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification

About the publisher IDA llms.txt

Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →

← 沛爾生醫-創 Back to newsroom (142)

Copied